Early glandular neoplasia of the lung

[1]  J S Lee,et al.  Clonal genetic alterations in the lungs of current and former smokers. , 1997, Journal of the National Cancer Institute.

[2]  V. Roggli,et al.  Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[3]  N. Müller,et al.  Glandular neoplasia of the lung. A proposed analogy to colonic tumors , 1988, Cancer.

[4]  A. Ochiai,et al.  High prevalence of atypical adenomatous hyperplasia of the lung in autopsy specimens from elderly patients with malignant neoplasms. , 2000, Lung cancer.

[5]  M. Yokozaki,et al.  Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis. , 1996, Modern Pathology.

[6]  J. Califano,et al.  Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. , 1996, Cancer research.

[7]  I. Wistuba,et al.  Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. , 1997, Cancer research.

[8]  J. Samet,et al.  Molecular damage in the bronchial epithelium of current and former smokers. , 1997, Journal of the National Cancer Institute.

[9]  R. Hruban,et al.  p53 alterations in atypical alveolar hyperplasia of the human lung. , 1998, Human pathology.

[10]  S. Rodenhuis,et al.  Clinical significance of ras oncogene activation in human lung cancer. , 1992, Cancer research.

[11]  M. Barbacid,et al.  Activation of ras oncogenes preceding the onset of neoplasia. , 1990, Science.

[12]  R. Hruban,et al.  Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.

[13]  S. Goodman,et al.  K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. , 1993, Cancer.

[14]  J. Herman,et al.  Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. , 1999, Journal of the National Cancer Institute.

[15]  Y. Nishiwaki,et al.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers , 1980, The American journal of surgical pathology.

[16]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[17]  K. Kerr,et al.  THE PATTERN OF K‐rasMUTATION IN PULMONARY ADENOCARCINOMA DEFINES A NEW PATHWAY OF TUMOUR DEVELOPMENT IN THE HUMAN LUNG , 1997, The Journal of pathology.

[18]  Y S Erozan,et al.  Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Y. Inayama,et al.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. , 1995, The American journal of pathology.

[20]  Takaaki Ito,et al.  Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma , 2000, The Journal of pathology.

[21]  S. Petersen,et al.  Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. , 1997, Cancer research.

[22]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[23]  Y. Nakamura,et al.  Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. , 1994, Cancer research.

[24]  R. Tsuchiya,et al.  Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[25]  J. Minna,et al.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[26]  W. Rom,et al.  Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. , 1995, Cancer research.

[27]  J. Gimferrer,et al.  Atypical adenomatous hyperplasia of the lung problems in operative management. , 2000, Lung cancer.

[28]  Y. Takeshima,et al.  Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung. , 1998, Hiroshima journal of medical sciences.

[29]  K. Nakanishi.  Alveolar epithelial hyperplasia and adenocarcinoma of the lung. , 1990, Archives of pathology & laboratory medicine.

[30]  D. Sidransky,et al.  Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. , 1999, Human pathology.

[31]  K. Kerr,et al.  Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53, and c‐erbB‐2 expression , 1994, The Journal of pathology.

[32]  Y. Nishiwaki,et al.  Monoclonality of atypical adenomatous hyperplasia of the lung. , 1999, The American journal of pathology.

[33]  A. Fraire,et al.  Alveolar cell hyperplasia in association with adenocarcinoma of lung. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[34]  W. Lam,et al.  Pulmonary scar cancer: A pathologic reappraisal , 1985, The American journal of surgical pathology.

[35]  K. Kerr,et al.  The association between atypical adenomatous hyperplasia and primary lung cancer , 2000, British Journal of Cancer.

[36]  J. Minna,et al.  Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. , 1995, JAMA.

[37]  R. Hruban,et al.  K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. , 1996, Cancer research.

[38]  Y. Shimosato,et al.  Morphometric study of adenocarcinomas and hyperplastic epithelial lesions in the peripheral lung. , 1986, American journal of clinical pathology.

[39]  D. Shibata,et al.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. , 1994, The American journal of pathology.

[40]  Takaaki Ito,et al.  Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma. , 1999, American journal of clinical pathology.

[41]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[42]  W. C. Ball,et al.  Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. , 2015, The American review of respiratory disease.

[43]  O. V. Paklina,et al.  [Atypical adenomatous hyperplasia of the lung]. , 2000, Arkhiv patologii.

[44]  D. Carter,et al.  Scar cancers of the lung: origin and significance. , 1984, Human pathology.

[45]  A. Kolin,et al.  Role of arterial occlusion in pulmonary scar cancers. , 1988, Human Pathology.

[46]  Y. Inayama,et al.  Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. , 1996, The American journal of surgical pathology.

[47]  K. Nakanishi,et al.  Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung. , 1998, Human pathology.

[48]  Tohru Takahashi,et al.  Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: Their heterology in form and analogy in immunohistochemical characteristics , 1996, Cancer.

[49]  K. Eguchi,et al.  Clinical investigation of atypical adenomatous hyperplasia of the lung. , 1999, Lung cancer.

[50]  Y. Nishiwaki,et al.  The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis. , 1997, Cancer.

[51]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.